TrueBlue (TBI) Misses Q2 EPS by 30c
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $9.94 +7.93%
EPS Growth %: +466.7%
Financial Fact:
Net income: 23.43M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +466.7%
Financial Fact:
Net income: 23.43M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
TrueBlue (NYSE: TBI) reported Q2 EPS of ($0.35), $0.30 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $396.23 million versus the consensus estimate of $414.49 million.
For earnings history and earnings-related data on TrueBlue (TBI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Wedbush Downgrades Compass Therapeutics (CMPX) to Neutral
- Decoy Therapeutics corrects warrant exercisability in inducement deal
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
